Ian Bone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ian Bone has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
G N Fuller
3 shared publicationsGeraint Fuller
2 shared publicationsD M Hadley
1 shared publicationG Fuller
1 shared publicationKeith W. Muir
Southern General Hospital
1 shared publicationSaif S M Razvi
Department of Neurology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, UK
1 shared publication
Latest Publications
- 1 June 2006
- Published by Springer Nature in Journal of Neurology
- Vol. 253 (6) , 685-700
Single gene disorders causing ischaemic stroke
Stroke is the third most common cause of death and the leading cause of long-term neurological disability in the world. Conventional vascular risk factors for stroke contribute approximately to only forty to fifty percent of stroke risk. Genetic factors may therefore contribute to a significant proportion of stroke and may be polygenic, monogenic or multi-factorial. Monogenic (single gene) disorders may potentially account for approximately one percent of all ischaemic stroke. Monogenic stroke disorders include conditions such as cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) and hereditary endotheliopathy, retinopathy, nephropathy and stroke (HERNS). In addition, other monogenic conditions such as sickle cell and Fabry disease also lead to stroke. These monogenic disorders cause either small vessel or large vessel stroke (or a combination of both) and serve as useful models for understanding and studying conventional stroke and cerebrovascular disease and its accompaniments such as vascular dementia.
- 1 June 2006
- Published by Springer Nature in Journal of Neurology
- Vol. 253 (6) , 685-700
Single gene disorders causing ischaemic stroke
Stroke is the third most common cause of death and the leading cause of long-term neurological disability in the world. Conventional vascular risk factors for stroke contribute approximately to only forty to fifty percent of stroke risk. Genetic factors may therefore contribute to a significant proportion of stroke and may be polygenic, monogenic or multi-factorial. Monogenic (single gene) disorders may potentially account for approximately one percent of all ischaemic stroke. Monogenic stroke disorders include conditions such as cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) and hereditary endotheliopathy, retinopathy, nephropathy and stroke (HERNS). In addition, other monogenic conditions such as sickle cell and Fabry disease also lead to stroke. These monogenic disorders cause either small vessel or large vessel stroke (or a combination of both) and serve as useful models for understanding and studying conventional stroke and cerebrovascular disease and its accompaniments such as vascular dementia.
- 1 March 2006
- Published by Springer Nature in Journal of Neurology
- Vol. 253 (3) , 401-402
Netter’s Neurology
- 1 March 2006
- Published by Springer Nature in Journal of Neurology
- Vol. 253 (3) , 401-402
Netter’s Neurology
- Open Access
- 1 December 2005
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 76 (suppl_5) , v1
Neurology in Practice: the final supplement--dementia
Before introducing the final supplement we would like to take this opportunity to thank our many contributors for giving their time and expertise to this project. This supplement has been a joint venture with the Association of British Neurologists and we are grateful for the Association’s financial support as well as the goodwill and hard work of so many of its members who have written for the supplement. We would also like to thank the staff at the JNNP, particularly the two editorial assistants we have worked with, Anastacia Kirk and Emilia Ioannou, our excellent unflappable technical editor, John Weller, and Janet Flaherty, BMJ Publishing Group Managing Editor. Also last, but not least, the good faith and trust of our founding Editor Chris Kennard and the continuing support and enthusiasm of the current Editor.
- 1 December 2005
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 76 (suppl_5) , v1
Open AccessNeurology in Practice: the final supplement--dementia
Before introducing the final supplement we would like to take this opportunity to thank our many contributors for giving their time and expertise to this project. This supplement has been a joint venture with the Association of British Neurologists and we are grateful for the Association’s financial support as well as the goodwill and hard work of so many of its members who have written for the supplement. We would also like to thank the staff at the JNNP, particularly the two editorial assistants we have worked with, Anastacia Kirk and Emilia Ioannou, our excellent unflappable technical editor, John Weller, and Janet Flaherty, BMJ Publishing Group Managing Editor. Also last, but not least, the good faith and trust of our founding Editor Chris Kennard and the continuing support and enthusiasm of the current Editor.
- Open Access
- 1 September 2005
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 76 (suppl_3) , iii29-iii38
Syndromes of the orbital fissure, cavernous sinus, cerebello- pontine angle, and skull base
The rate of presentation, with or without more widespread neurological or systemic involvement, hints at the particular pathological process at play.
- 1 September 2005
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 76 (suppl_3) , iii29-iii38
Open AccessSyndromes of the orbital fissure, cavernous sinus, cerebello- pontine angle, and skull base
The rate of presentation, with or without more widespread neurological or systemic involvement, hints at the particular pathological process at play.
- Open Access
- 1 June 2004
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 75 (suppl_2) , ii1
Neuro-oncology
Reliable data on large cohorts of patients with glioblas- toma are needed because such studies differ importantly from trials that have a strong bias toward the recruit- ment of younger patients with a higher performance sta- tus. We analyzed the outcome of 676 patients with histo- logically confirmed newly diagnosed glioblastoma who were treated consecutively at a single institution over a 7-year period (1997 - 2003) with follow-up to April 30, 2006. Survival probabilities were 57% at 1 year, 16% at 2 years, and 7% at 3 years. Progression-free survival was 15% at 1 year. Prolongation of survival was signifi - cantly associated with surgery in patients with a good performance status, whatever the patient's age, with an adjusted hazard ratio of 0.55 (p , 0.001) or a 45% relative decrease in the risk of death. Radiotherapy and Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma chemotherapy improved survival, with adjusted hazard ratios of 0.61 (p 5 0.001) and 0.89 (p 5 0.04), respec- tively, regardless of age, performance status, or residual tumor volume. Recurrence occurred in 99% of patients throughout the follow-up. Reoperation was performed in one-fourth of these patients but was not effective, whether performed within 9 months (hazard ratio, 0.86; p 5 0.256) or after 9 months (hazard ratio, 0.98; p 5 0.860) of initial surgery, whereas second-line che-
- 1 June 2004
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 75 (suppl_2) , ii1
Open AccessNeuro-oncology
Reliable data on large cohorts of patients with glioblas- toma are needed because such studies differ importantly from trials that have a strong bias toward the recruit- ment of younger patients with a higher performance sta- tus. We analyzed the outcome of 676 patients with histo- logically confirmed newly diagnosed glioblastoma who were treated consecutively at a single institution over a 7-year period (1997 - 2003) with follow-up to April 30, 2006. Survival probabilities were 57% at 1 year, 16% at 2 years, and 7% at 3 years. Progression-free survival was 15% at 1 year. Prolongation of survival was signifi - cantly associated with surgery in patients with a good performance status, whatever the patient's age, with an adjusted hazard ratio of 0.55 (p , 0.001) or a 45% relative decrease in the risk of death. Radiotherapy and Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma chemotherapy improved survival, with adjusted hazard ratios of 0.61 (p 5 0.001) and 0.89 (p 5 0.04), respec- tively, regardless of age, performance status, or residual tumor volume. Recurrence occurred in 99% of patients throughout the follow-up. Reoperation was performed in one-fourth of these patients but was not effective, whether performed within 9 months (hazard ratio, 0.86; p 5 0.256) or after 9 months (hazard ratio, 0.98; p 5 0.860) of initial surgery, whereas second-line che-
- Open Access
- 1 March 2004
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 75 (90001) , 1i-1
NEUROLOGICAL INFECTION AND INFLAMMATION
- 1 March 2004
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 75 (90001) , 1i-1
Open AccessNEUROLOGICAL INFECTION AND INFLAMMATION
- 1 January 2004
- Published by Springer Nature in Neurocritical Care
- Vol. 1 (3) , 319-330
Basilar Artery Occlusion
Basilar artery occlusion is assumed to carry a grave prognosis, with mortality rates of up to 90%. Diagnosis is often delayed, or even missed, as a result of the variety of clinical presentations seen with this condition. The pathogenesis of occlusion can be secondary to both local atherothrombosis or cardioembolism. The use of noninvasive imaging such as magnetic resonance imaging and computed tomography angiography has improved recognition of clinical syndromes associated with occlusion. Although no randomized studies have been performed, recanalization of the vascular occlusion, particularly with thrombolytic agents, appears to result in improved outcomes in selected patients. However, the optimum timing for therapy is unclear, and reperfusion therapy may need to be combined with definitive vascular treatment of underlying vascular stenosis. Increasing awareness of this condition may reveal the natural history to be more diverse than previously recognized.
- 1 January 2004
- Published by Springer Nature in Neurocritical Care
- Vol. 1 (3) , 319-330
Basilar Artery Occlusion
Basilar artery occlusion is assumed to carry a grave prognosis, with mortality rates of up to 90%. Diagnosis is often delayed, or even missed, as a result of the variety of clinical presentations seen with this condition. The pathogenesis of occlusion can be secondary to both local atherothrombosis or cardioembolism. The use of noninvasive imaging such as magnetic resonance imaging and computed tomography angiography has improved recognition of clinical syndromes associated with occlusion. Although no randomized studies have been performed, recanalization of the vascular occlusion, particularly with thrombolytic agents, appears to result in improved outcomes in selected patients. However, the optimum timing for therapy is unclear, and reperfusion therapy may need to be combined with definitive vascular treatment of underlying vascular stenosis. Increasing awareness of this condition may reveal the natural history to be more diverse than previously recognized.
- Open Access
- 1 December 2003
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 74 (90004) , 1iv-2
Neurological rehabilitation, uro-neurology, and motor neurone disease
- 1 December 2003
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 74 (90004) , 1iv-2
Open AccessNeurological rehabilitation, uro-neurology, and motor neurone disease
- 1 September 2003
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 74 (90003) , 16iii-23
Neurological consultations in the medical intensive care unit
- 1 September 2003
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 74 (90003) , 16iii-23
Neurological consultations in the medical intensive care unit
- 1 September 2003
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 74 (90003) , 1iii-1
Intensive care neurology and the autonomic nervous system
- 1 September 2003
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 74 (90003) , 1iii-1
Intensive care neurology and the autonomic nervous system